ArticleBMC medicine2026
Long-term risk of offspring type 1 and type 2 diabetes following maternal gestational diabetes mellitus: a nationwide birth cohort study with 10-year follow-up.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Machine learning-based prediction model for adverse pregnancy outcomes in women with gestational diabetes mellitus.Journal of diabetes investigation · 2026Article
- Hyperglycemia during the first 1000 days as a driver of metabolic programming.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundEvidence on the individual risks of type 1 and type 2 diabetes following gestational diabetes mellitus (GDM) exposure, particularly in large Asian populations, remains limited. We examined whether maternal GDM increases the risk of type 1 and type 2 diabetes in offspring in a Korean nationwide cohort.
methodsAfter excluding mothers with preexisting diabetes, we analyzed a nationwide Korean birth cohort of 3,491,680 mother-child pairs from 2009 to 2018, followed for up to 14 years. Type 1 diabetes was defined as International Classification of Diseases, 10th Revision (ICD-10) E10 with insulin prescription; type 2 diabetes as ICD-10 E11-E14 with antidiabetic medication use. Cox proportional hazards models were used to estimate hazard ratios (HRs) across three groups, offspring born to mothers without GDM (reference), with GDM but not treated with insulin, and with GDM treated with insulin, adjusting for maternal and neonatal covariates.
resultsOf the total cohort, 424,185 (12.1%) pregnancies were complicated by GDM, among which 30,003 (7.1%) required insulin therapy during pregnancy. GDM without insulin therapy was not associated with type 1 diabetes in offspring (HR, 0.857 [95% confidence interval, 0.696-1.054]). However, offspring of GDM mothers requiring insulin during pregnancy had a higher risk of type 1 diabetes (HR, 1.936 [1.228-3.052]). For offspring type 2 diabetes, GDM without insulin during pregnancy was significantly associated with increased risk (HR, 1.281 [1.146-1.433]), with a greater risk among insulin-treated GDM pregnancies (HR, 4.329 [3.555-5.270]).
conclusionsMaternal GDM without insulin therapy is associated with an increased risk of type 2 diabetes, but not type 1 diabetes, in offspring, whereas insulin treatment for GDM during pregnancy is associated with increased risk for both type 1 and type 2 diabetes. These findings underscore the need for individualized postnatal monitoring for offspring of mothers with GDM, with heightened attention for those whose mothers required insulin therapy during pregnancy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.